Clinical Study
Revisiting the Role of First Trimester Homocysteine as an Index of Maternal and Fetal Outcome
Table 4
Homocysteine levels with reference to fetal outcome of present pregnancy.
| | No fetal congenital malformation ( = 88) | Fetal congenital malformation ( = 2) | value | Statistical test used |
| Serum homocysteine (mol/L) | 14.56 ± 8.0 | 12.07 ± 1.75 | 0.6621 | Mann-Whitney test |
| | No pregnancy loss ( = 82) | Pregnancy loss ( = 8) | | |
| Serum homocysteine (mol/L) | 13.51 ± 7.47 | 24.65 ± 4.51 | 0.0002
**
| Mann-Whitney test |
| | Clear amniotic fluid ( = 67) | Meconium stained amniotic fluid ( = 17) | | |
| Serum homocysteine (mol/L) | 12.52 ± 6.94 | 18.43 ± 8.48 | 0.0037
*
| Mann-Whitney test |
| | No oligohydramnios ( = 66) | Oligohydramnios ( = 18) | | |
| Serum homocysteine (mol/L) | 12.58 ± 7.01 | 20.02 ± 7.92 | <0.0001
**
| Mann-Whitney test |
| | Birth weight ≥2500 gm ( = 73) | Birth weight <2500 gm ( = 11) | | |
| Serum homocysteine (mol/L) | 12.35 ± 5.64 | 23.22 ± 12.32 | 0.0224
*
| Unpaired -test—Welch correction |
|
|
significant.
**
highly significant.
|